Surrozen Inc: Treatment With Szn-043 in Phase 1a Trial Was Safe & Well Tolerated in Healthy Volunteers and Patients With a History of Liver Cirrhosis
Surrozen公司:Szn-043在1a期臨床試驗中對於健康志願者和有肝硬化病史的患者來說是安全的且耐受良好。
Surrozen Inc: Treatment With Szn-043 in Phase 1a Trial Was Safe & Well Tolerated in Healthy Volunteers and Patients With a History of Liver Cirrhosis
Surrozen公司:Szn-043在1a期臨床試驗中對於健康志願者和有肝硬化病史的患者來說是安全的且耐受良好。
譯文內容由第三人軟體翻譯。